Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Chiarini

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Hematological Oncology|February 14, 2023
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantationLorenzo Masina, Nicola Bianchetti, Angela Passi, et al.
Immunobiology|April 22, 2023
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasisManuela Baronio, Luisa Gazzurelli, Sara Rezzola, et al.
European Journal of Immunology|June 28, 2020
Immune response in children with COVID-19 is characterized by lower levels of T-cell activation than infected adultsDaniele Moratto, Mauro Giacomelli, Marco Chiarini, et al.
Non-Coding RNA|May 5, 2019
Circulating microRNAs and Their Role in Multiple MyelomaCinzia Federico, Antonio Sacco, Angelo Belotti, et al.
American Journal of Hematology|July 23, 2020
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemiaFrancesco Mannelli, Giacomo Gianfaldoni, Sara Bencini, et al.
Frontiers in Pediatrics|August 15, 2022
Abnormal B-Cell Maturation and Increased Transitional B Cells in CBL SyndromeFrancesco Saettini, Tiziana Angela Coliva, Francesca Vendemini, et al.
Future Oncology (London, England)|July 13, 2021
AMELIORATE: early intensification in <i>FLT3</i>-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trialFrancesco Mannelli, Giacomo Gianfaldoni, Paola Guglielmelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 13, 2024
Older Adults with Ph Negative Acute Lymphoblastic Leukemia: A Monocentric Experience on 57 Patients Focusing on Treatment Intensity and Age-Related PrognosisErika Borlenghi, Tatiana Zollner, Giuseppe Rossi, et al.
Plos One|April 12, 2017
Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantationCristina Skert, Simone Perucca, Marco Chiarini, et al.
Journal of Translational Medicine|April 18, 2020
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patientsMarco Chiarini, Ruggero Capra, Federico Serana, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Hematological Oncology|February 14, 2023
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantationLorenzo Masina, Nicola Bianchetti, Angela Passi, et al.
Immunobiology|April 22, 2023
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasisManuela Baronio, Luisa Gazzurelli, Sara Rezzola, et al.
European Journal of Immunology|June 28, 2020
Immune response in children with COVID-19 is characterized by lower levels of T-cell activation than infected adultsDaniele Moratto, Mauro Giacomelli, Marco Chiarini, et al.
Non-Coding RNA|May 5, 2019
Circulating microRNAs and Their Role in Multiple MyelomaCinzia Federico, Antonio Sacco, Angelo Belotti, et al.
American Journal of Hematology|July 23, 2020
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemiaFrancesco Mannelli, Giacomo Gianfaldoni, Sara Bencini, et al.
Frontiers in Pediatrics|August 15, 2022
Abnormal B-Cell Maturation and Increased Transitional B Cells in CBL SyndromeFrancesco Saettini, Tiziana Angela Coliva, Francesca Vendemini, et al.
Future Oncology (London, England)|July 13, 2021
AMELIORATE: early intensification in <i>FLT3</i>-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trialFrancesco Mannelli, Giacomo Gianfaldoni, Paola Guglielmelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 13, 2024
Older Adults with Ph Negative Acute Lymphoblastic Leukemia: A Monocentric Experience on 57 Patients Focusing on Treatment Intensity and Age-Related PrognosisErika Borlenghi, Tatiana Zollner, Giuseppe Rossi, et al.
Plos One|April 12, 2017
Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantationCristina Skert, Simone Perucca, Marco Chiarini, et al.
Journal of Translational Medicine|April 18, 2020
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patientsMarco Chiarini, Ruggero Capra, Federico Serana, et al.
Pageof 10